HIV Prevention: A Proven Solution Eludes Many Due to Systemic Barriers

Proven Treatment Underutilized:
Despite being a highly effective method to reduce HIV infection risk by up to 99%, PrEP is used by fewer than 1 in 4 people who would benefit from it in the United States.

Disparities in Access:
People who are Black or Hispanic/Latino are overrepresented in new HIV diagnoses but have lower rates of PrEP prescriptions, highlighting significant disparities in access to preventive care.

Stigma and Awareness:
Stigma around HIV and sex, particularly among women and marginalized groups, contributes to low PrEP uptake. Nonjudgmental and culturally relevant care can help reduce stigma and increase awareness.

Systemic Barriers:
Medical provider-, clinic-, and system-level barriers hinder PrEP knowledge, access, and uptake in communities that could benefit from it, emphasizing the need for comprehensive and inclusive healthcare strategies.

Innovative Solutions:
Programs like TelePrEP and next-generation HIV prevention products, such as longer-acting implants and vaginal rings, offer promising solutions to increase PrEP accessibility and adherence.

Global Context:
The global HIV epidemic faces similar challenges, with many countries lacking access to comprehensive HIV prevention services, including PrEP, due to funding and policy issues.

CDC Priorities:
The CDC emphasizes high-impact strategies, including PrEP and syringe service programs, to reduce new HIV infections and improve outcomes for people with HIV, focusing on populations and geographic areas most affected by HIV.